Adage Capital Partners
ADMA icon

Adage Capital Partners’s ADMA Biologics ADMA Stock Holding History

Adage Capital Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,767,558
Closed -$13.5M – 846
2023
Q3 		$13.5M Buy
3,767,558
+493,000
+15% +$1.9M 0.03% 502
2023
Q2 		$12.1M Sell
3,274,558
-350,000
-10% -$1.3M 0.03% 533
2023
Q1 		$12M Buy
3,624,558
+1,023,558
+39% +$3.54M 0.03% 573
2022
Q4 		$10.1M Buy
+2,601,000
New +$8.02M 0.02% 636

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Adage Capital Partners's ADMA Position: Q4 2023 in Review

Adage Capital Partners sold out of ADMA Biologics (ADMA) in Q4 2023, closing a stake of 3,767,558 shares — an estimated $13.5M sold.

Adage Capital Partners first reported a position in ADMA in Q4 2022 and held it in 4 quarters. The position peaked at $13.5M in Q3 2023. 184 funds tracked by Wall St. Rank hold ADMA as of Q4 2023.

  • Adage Capital Partners reported no remaining ADMA Biologics position as of Q4 2023 after selling out during the quarter.
  • Adage Capital Partners sold 3,767,558 ADMA Biologics shares in Q4 2023, an estimated $13.5M.
  • Adage Capital Partners first reported a position in ADMA Biologics in Q4 2022 and held it in 4 quarters.
  • Adage Capital Partners's ADMA Biologics position peaked at $13.5M in Q3 2023.
  • 184 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2023.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.